Introduction

I
t is estimated that 500,000 to 1,000,000 vasectomies are performed formalesterilization annually in the United States representing a solutionfor 12% ofall married couples. Excludinginfidelity, earlyunprotected intercourse, or technical failure , the pregnancy rate following vasectomy is less than 0.1 per 100 women-years.' Its applicability to the office setting and performance under local anesthesia lends itself to wide acceptance. Nevertheless, despiteits advantages and acceptance, vasectomy has some well-known complications and remainsan intellectually flawed procedure. Some compllcations of vasectomy are related directly to the surgicaltechnique and include postoperative hemorrhage, vagovasal reactions, postoperative infection, persistent motile or nonmotile sperm, poor patient selection resulting in intraoperative difficulty finding the vas, termination ofthe procedure due to pain, and rapidrequestforre-establishment offertility through vasovasostomy.
Another complication, which is composed of a number of symptoms and physical findings, could best be grouped under the title of chronic postvasectomy pain syndrome (CPVPS). In olderreviews ofvasectomy outcomes, CPVPS has not beenmentioned as a compllcation.' However, in more recent articles regarding complications ofvasectomy, chronic scrotalpain is now considered to be a negative factor in surgical outcome. In additionto variousmedical therapies, several inventive surgical procedureshave been described to address this complication. Yet, the use ofintramuscular(1M) testosterone to treat this condition is not mentioned in the literature and this shortcoming is difficult to explain given the nature of the problem, namely, the continued production of antigenic spermatozoa, Therapies which donot address this core issue areineffective, misdirected, and possibly injurious. In military and civilian practices alike, chronic scrotal pains from a variety of sources are a frequent pres~nting symptom to the physician's office. Athorough diagnostic approach to all such pains is necessary, and, since the perplexing and contradictory solutionsfrequently overlap, they are included in this article.
Case Report
A 36-year-old patient presented with a history of having a vasectomy performed 6 years earlier. Approximately 6 months following his operation, he returnedto the original urologist with complaints ofa painful lumpin the upper portion ofthe leftside of the scrotum. After a course of antibiotics was unsuccessful he sought the opinion ofa second urologist who recommended excision of the mass. This second procedure of excision of a presumed sperm granuloma resulted in a pain-free state for approximately 5 years. The patient then developed pain in the leftsideofthe scrotumand he returned to the second urologist who, after an unsuccessful course ofantibiotics, recommended a left epididymectomy. Atthis point, the patient soughtanother option. On presentation, the patient had a slightly tender and enlarged left epididymis and slightly tender testicle and spermatic cord. On scrotal ultrasound, there was no evidence of varicocele, testiculartumor, or hydrocele. Acourseoftestosterone cypionate 400 mg monthly 1M for 3 months was recommended. The patient reported decrease in pain within 2 weeks and has been pain-free for more than 1 year after receiving the courseof three injections.
Discussion
Theincidence ofCPVPS is reported to rangefrom 0.1% to 54% depending on definitions of severity and duration, Choe and Kirkemo" found 25.3% ofpatients to have chronic scrotalpains and epididymitis following vasectomy, ofwhom 70.6% reported occasional pain and 2.2% reported pain as sufflctently severe to cause an impacton the quality oflife, They alsoemphasized the necessity of inclusion of chronic, postoperative pain in their vasectomy consentsincepainhas beenthe subjectofltttgatton." The pain is due to the interruption of the efferent sperm ducts with continued sperm production resulting in either sperm granuloma at thevasectomy site and/or epididymal obstruction and granuloma. ' Athorough history shouldbe taken sinceCPVPS is defined as intermtttent or constant; unilateral, bilateral, or alternating; and lasting more than 3 months, On initial presentation, the historyofprevious surgery is essential, forCPVPS is one possibility in the more generalized condition ofvariousinguinal and scrotalpains.Troublesome pains preceding and following mgut-nal herniorrhaphy, varicocelectomy, spermatocelectomy, and hydrocelectomy are well-known. In additionto previoussurgery, a history should include symptoms related to infections due to epididymitis, prostatitis, and seminalvesiculitis, and inflammatory conditionssuch as interstitial cystitis. Ahistoryoftrauma, possibly on the job injury, back pain, other chronic pain, and psychiatric disorders should be elicited. Chronic intermittent torsion,tumor, retroperitoneal fibrosis, periarteritisnodosa,epilepsy, self-palpation orchitis, aneurysms of the common iliac artery, intervertebral disc protrusion, diabetic neuropathy, gout, 5 and pudendal nerve entrapment" have been listed as potential causes of orchialgia. Vasectomy may have been performed long ago and questions should be asked directly to establish a possible cause.
On physical examination, tenderness is maximal about the epididymis; however, tenderness may be present in the spermatic cord, inguinal canal, and testis. The presence ofa varicocele, testicular mass, hydrocele, sperm granuloma, spermatocele, or Inguinal hernia should be sought. Referred pain from a kidneyshould be considered and ruled out.
Aurinalysis and scrotal ultrasound are essential and should be orderedto establish the absence ofmicrohematuria, nonpalpable tumor, Varicocele, or epididymal mass. A noncontrast computed tomography scan of the abdomen and pelvis should be considered to determine any contribution of lithiasis, retroperitoneal mass, or vascular causes.
Treatments for scrotal pains in general and postvasectomy pain in particular should be directed toward their obvious causes. However, when the history, the physical examination, laboratory tests, and imaging studies result in pain as a diagnosis, treatments for pain are initiated. These treatments are medical and surgical and it is generally accepted that medical treatments should be tried first. Such medical treatments have included antibiotics, steroidal and nonsteroidal anti-inflammatory agents, antidepressants, narcotic analgesics, a-blocking agents, and anticonvulsants. Pain clinic consultation with resultant nerve blocks and neurostimulators, and psychiatric consultation are descrtbed" The problem of secondary gain from on-the-jobinjuries, litigation, and court settlements must be accepted as a detractor from any acceptable medical resolution. Surgical treatments have included excision of a sperm granuloma, epididymectomy, vasovasostomy and vasoepididymostomy,? tngumal orchiectomy,'? laparoscopic testicular denervation," microsurgical denervation of the spermatic cord," and decompression of the pudendal nerve. In general, articles describing surgical treatments are favorable toward their own approach. Daviset al.10 reported 34 patients with chronicscrotal pain ofvarious etiologies. Ofthose treated with epididymectomyinitially, 90%went on to have tngutnalorchiectomy, and of those treated with Inguinalorchiectomy, 73% experienced complete relief. In contrast, Costabile et al." analyzed 48 patients with chronicscrotal pains ofundeterminedetiology who underwent 74 different surgical procedures and found that of 31 available patients after 8 years, none had resolution of symptoms. Ofthose patients who underwent orchiectomy, 80% continued to complain of scrotal pain. Their conclusion was that invasive procedures should be avoided.
The neurological innervations of the testis, vas, and epididymis are complex and confusing due to parallelnomenclature for 677 identicalstructures. However, onlyafferentsare germaneIn this discussion. Somatic afferents from the tunica vaginalis and cremasterreceive innervationoriginating in Ll-L2carriedbythe genitalbranch ofthe genitofemoral nervewith cellbodiesin the dorsal root ganglia. Visceral afferents from the vas deferens, epididymis, and testis follow the spermatic vessels to branch to the inferior spermatic plexus, superior spermatic plexus, and inferior hypogastric plexus (sympathetics) ofT lO-Ll.Thepelvic splanchnic nerve (parasympathetic) carries afferents to the S2-S4dorsalrootganglia. Although most visceral afferentshave their cellbodiesin the dorsal roots, somevisceralafferentsenter the spinal cordviaventralroots. It has been proposedthat these afferentsmay participatein nociception. Sproutingbetween axons either at the level ofthe dorsal root ganglion or at the dorsal hom has beenpostulated as a cause ofchronic, afterinjurypain with reroutingofSignals from a light touch to a pain pathway. 13 To prevent pathological pain from developing postvasectomy, injection ofa local anesthetic into the abdominalside ofthe vas lumen duringthe procedurehas been studied. Itwas postulated that sensitization ofthe dorsal hom can occur and subsequent tactile sensation can be carried via unmyelinated afferent C-fibers inducing painful sensation. 14 The dual functions of the testis, hormone production and spermatogenesis, are regulated by secretion of the pituitary gonadotrophins, luteinizing hormone(LH), and follicle-stimulating hormone (FSH). In tum , the gonadotrophins are under the control of GnRH from the hypothalamus, with inhibitory feedback via steroid and peptide hormones from the testicle. LH stimulates the production of testosterone from the Leydig cells in the testis and FSH acts on receptors in the Sertoli cells. Although FSH is necessary for the normal development of the fetal testis, it appears to have an auxiliary role in spermatogenesis in adults since experimental evidenceindicates spermatogenesis can proceedwith testosterone stimulation alone. However, spermatogenesis cannot proceed without normal intratesticular testosteronelevels. Testosterone executes its affect on the Sertoli cell. The intratesticular testosterone concentration in humans is approximately 100 times higher than that in serum. A decrease of only20% of normal in the intratesticular testosterone level in rats was sufficient to cause an arrest of spermatogenesis.15, 16 Exogenously administered testosteronehas been proposed as a contraceptive in the malebysuppressing LH and FSH from the pituitary.Two studies fundedby the World HealthOrganization have shown that azoospermia can be produced by testosterone injectionsin 60% to 70% ofCaucasians and 95%ofAsianmen. Severe oligospermia with counts of 3 million per milliliter occurred in the 30% of those who did not become azoospermic. Although reports state that this suppression is completely reversible, the testosterone rebound treatment for infertility is condemned due to the occasional conversion ofoligospermia to permanent azoospermia through testosterone treatment." Although the ideal male contraceptive is yet to be developed, the efficacy oftestosterone in the arrest ofspermatogenesis is wellestablished.
1M, exogenous testosterone substitution for endogenous productionwouldappear to be free ofhealth risks-especiallyforthe short-term. Oralagents, particularlythe 17-alkylated derivative of testosteronewere toxicto hepatocytes due to high first-pass metabolism, are not recommended here. In hypotestosteronemic conditions, replacement with patches, gels, and buccal suppositories has had success. These administrative routes were not attempted here and have been less successful in inducing azoo-and oligospermia in family planning studies than the 1M route. The multisystem affects oftestosterone are generallysafe; however, absolute contraindications to administration would be breast carcinomain men and prostate cancer. Relative contraindications are severe cardiac, renal, or hepatic disease, polycythemia, and sleep apnea.i8
Aspermatogenic autoantigens are expressed only by germ cellsand can elicitan immune responsethat causes diminished sperm production and damage to germ cells. The expressionof these autoantigens postdate the early lymphocyte interactions that confer immunologic toleranceofselfantigens. It is not until puberty that new antigenic expression takes place on maturing spermatozoa thereby rendering them foreign to the immune system. A major anatomic and physiologic mechanism for isolation of the testis immunologically is the blood-testes barrier: tight junctions at the apical regions of Sertoli cells isolate the luminal germ cells from immunologic surveillance. In humans, vasectomy as been associatedwith the subsequent development of antisperm antibodies in approximately 50% to 800!& of men. Although fertility can be re-established following vasectomy reversal, decline in fecundity has been ascribed to an increased prevalence of antisperm antibodieswith time.19Whethervasec-tomy was done with the testicular side open to allow a sperm granuloma to develop" and relieve blow-out pressure on the epididymis, or sealed with clips, cauterization, or ligatures with resultant sperm extravasation in the epididymis, it is certain that the normal epithelialbarriers are breached.
Additionally, the concern of autoimmunization to spermatozoa has been an ongoing concernin the best methodfor scrotal fixation of testicular torsion to prevent the possibility of future infertility although exposure is comparatively minor." The resultant exposure ofsperm leads to macrophage phagocytosis and causes the individual to elicit responses to "self" antigens. Both humoral and cell-mediated responses are implicated in various inflammatory conditions. The presence of sperm granulomas has been noted on one or both sides in 40% of patients following vasectomy, and at vasectomy reversal in 30% to 60% of patients. Distention of the epididymis is uniformly seen during vasectomy reversal and ultrasound studies suggest postvasectomy sperm granulomas are common in the epididymis. These cream-colored nodules occurringat the severed end of the vas or epididymis consist of a central mass of degenerating spermatozoasurrounded by a layer of epithelioid macrophages, surrounded in tum by loose connective tissue rich in lymphocytes and plasma cells. Analysis offluid aspirated from symptomatic spermatoceles has yielded high levels of interleukin6, interleukin8, and tumor necrosisfactor a, allpromflammatory cytokines.
Although the literature recognizes the association of intractable pain following vasectomy leadingto recommendations for innovative but extensive medical and surgical treatments with less than total satisfaction, there is no mention of the use of testosteroneto treat this condition. It appears that the relentless production of sperm with its associated antigenicity and pressure effects would best be served by the administration of tesMilitary Medicine, Vol. 172, June 2007
Case Report tosterone for a briefperiodoftime to eliminate the cause of the problem bythe inductionofsevereoligospermia or azoospermia. Certainly, the resultant azoospermia of the testosterone rebound treatment is ofno issue since the patient desiredpermanent sterilityregardless. Ifthe reliefwereto last forsome period oftime and recur, it could be easily repeated. No prohibition from other therapies is implied and they can certainly be performed if the patientwas unresponsive to testosterone treatment.
The use oftestosterone treatment is possiblein other painful scrotal conditions in which occlusion of the efferent ducts is possibleprovided there is no contraindication, e.g., postoperativetesticular pain in a patient with prostate cancer or a young male with pain from any of a variety of conditions if future fertility could be problematic.
Conclusion
Vasectomy is a common, effective, and permanent procedure for male sterility. Immediate and long-term complications have been well-described. In recent years, increasing concern and recognition of the CPVPS is apparent in articles describing vasectomy as a procedure and in methods, mainly surgical, to alleviate the unrelenting discomfort. The cause of the CPVPS is the continued production of sperm which are antigenic and provoke humoral and cellularantibodyand inflammatory cytokine responses. No proposed method, surgical or medical, has addressed this cause, exceptfor vasovasostomy, which defeats the purpose of vasectomy or is done in the face of proximal epididymal blowout and would be ineffective. Whethernociceptic reflexes or neuronal reroutingis independent or synergistic with these inflammatory responses remains to be determined. Testosterone cypionate administered 1M in 400 mg doses monthly for 3 months is an effective, frequently permanent, solution to this problem and should be used in all first-line cases of CPVPS. Why this has not been previously published is unknown.
